Cited by 521Lipoproteins and Cardiovascular HealthGenetic Associations and EpidemiologyAtherosclerosis and Cardiovascular Diseases

The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.

Lipoprotein(a): resurrected by genetics

Open access

Kronenberg, F., Utermann, G.·2013·Journal of Internal Medicine

DOI 10.1111/j.1365-2796.2012.02592.x

Open this paper in CoChat — free account Open PDF

Abstract

Plasma lipoprotein(a) [L p(a)] is a quantitative genetic trait with a very broad and skewed distribution, which is largely controlled by genetic variants at the LPA locus on chromosome 6q27. Based on genetic evidence provided by studies conducted over the last two decades, L p(a) is currently considered to be the strongest genetic risk factor for coronary heart disease (CHD). The copy number variation of kringle IV in the LPA gene has been strongly associated with both L p(a) levels in plasma and risk of CHD, thereby fulfilling the main criterion for causality in a M endelian randomization approach. Alleles with a low kringle IV copy number that together have a population frequency of 25–35% are associated with a doubling of the relative risk for outcomes, which is exceptional in the field of complex genetic phenotypes. The recently identified binding of oxidized phospholipids to L p(a) is considered as one of the possible mechanisms that may explain the pathogenicity of L p(a). Drugs that have been shown to lower L p(a) have pleiotropic effects on other CHD risk factors, and an improvement of cardiovascular endpoints is up to now lacking. However, it has been established in a proof of principle study that lowering of very high L p(a) by apheresis in high‐risk patients with already maximally reduced low‐density lipoprotein cholesterol levels can dramatically reduce major coronary events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2796.2012.02592.x

Cites

204 of 204 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citation
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., & Wanner, C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00273.x · Cited by 1,531
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,383

Show all 203 references

Research works printed but not linked: 2

Utermann G, 2000, The Metabolic & Molecular Bases of Inherited Disease, 2753
10.1210/jc.81.7.2633 · DOI

Sorted by citations

Items 301–400 of 521

Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis
Klingel, R., Heigl, F., Schettler, V. J. J., Roeseler, E., Grützmacher, P., Hohenstein, B., Vogt, A., Fassbender, C., Heibges, A., & Julius, U. (2019) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2019.08.037 · Cited by 11
Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a)
Gonen, A., Yang, X., Yeang, C., Alekseeva, E. A., Koschinsky, M. L., Witztum, J. L., Boffa, M. B., & Tsimikas, S. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000830 · Cited by 11
Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
Afanasieva, O. I., Владиславович, Е. М., Tmoyan, N. A., Андреевна, Р. О., Afanasieva, M. I., Matchin, Y. G., & Pokrovsky, S. N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.843602 · Cited by 10
Plasma Lipoprotein(a) Levels in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis
Masson, W. M., Barbagelata, L., Lobo, M., Cobo, A. L., Corral, P., & Nogueira, J. P. (2023) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-023-00585-2 · Cited by 12
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease, the Impact of Available Lipid-Lowering Medications on Lipoprotein(a): An Update on New Therapies
Tsushima, T., Tsushima, Y., Sullivan, C., & Hatipoğlu, B. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.12.011 · Cited by 9
Value of Genetic Testing for Lipoprotein(a) Variants
Langsted, A., & Nordestgaard, B. G. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.122.003737 · Cited by 10
Lipoprotein (a): Does It Play a Role in Pediatric Ischemic Stroke and Thrombosis?
Torres, M. D., & Schenk, A. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01102-5 · Cited by 9
Ancestral diversity in lipoprotein(a) studies helps address evidence gaps
Lee, M. P., Dimos, S. F., Raffield, L. M., Wang, Z., Ballou, A. F., Downie, C. G., Arehart, C. H., Correa, A., de Vries, P. S., Du, Z., et al. (2023) · Open Heart · doi:10.1136/openhrt-2023-002382 · Cited by 9
Elevated lipoprotein(a) levels: A crucial determinant of cardiovascular disease risk and target for emerging therapies
Afzal, Z., Cao, H., Chaudhary, M. A., Chigurupati, H. D., Neppala, S., Alruwaili, W., Awad, M. A., Sandesara, D., Siddique, M., Farman, A., et al. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102586 · Cited by 9
Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels
Malaguarnera, G., Latteri, S., Catania, V. E., & Malaguarnera, M. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.08.67 · Cited by 9
Lipoprotein(a): A Residual Cardiovascular Risk Factor in Statin-Treated Stroke Survivors
Chemello, K., Gallo, A., Guédon, A. F., Techer, R., Croyal, M., Swietek, M. J., Meilhac, O., Amarenco, P., & Lambert, G. C. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100557 · Cited by 11
LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels
Likozar, A. R., Blinc, A., Podkrajšek, K. T., & Šebeštjen, M. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8120181 · Cited by 9
Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family
Nikkola, E., Ko, A., Alvarez, M., Cantor, R. M., Garske, K. M., Kim, E., Gee, S., Rodríguez, A., Muxel, R., Matikainen, N., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.07.024 · Cited by 9
Self-citation
Clinical Application of Genetic Testing in Heart Failure
Morales, A., & Hershberger, R. E. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0366-4 · Cited by 9
The influence of lipoprotein(a) on aortic valve calcification in patients undergoing transcatheter aortic valve replacement
Bormann, J., Rudolph, F., Miller, M., Waezsada, S., Kirchner, J., Bleiziffer, S., Friedrichs, K. P., Rudolph, V., Rudolph, T. K., & Gerçek, M. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02587-z · Cited by 8
The nonlinear association between lipoprotein(a) and major adverse cardiovascular events in acute coronary syndrome patients with three-vessel disease
Li, Q., Xu, S., Shen, J.-X., & Sun, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-86154-0 · Cited by 8
Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Pfeferman, M. B., Rashedi, S., Lip, G. Y. H., Weber, C., O’Donoghue, M. L., Nissen, S. E., Nicholls, S. J., Natarajan, P., Plutzky, J., Libby, P., et al. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2674-5114 · Cited by 10
The biology of lipoprotein(a): From genetics to molecular mechanisms
Atallah, Nasrallah, N., Harb, T., Gerstenblith, G., & Leucker, T. M. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70133 · Cited by 9
Apolipoproteins in Chronic Kidney Disease and Kidney Transplant: A Long Unfinished Story
Secondulfo, C., Izzo, C., Vecchione, N., Minelli, G., Russo, D., Russo, D., Barra, R., Molinaro, G., Apicella, L., Iacuzzo, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199664 · Cited by 10
Diabetes Mellitus and Lipoprotein(a): A Determinant Interaction in Micro- and Macrovascular Damage
Polo-Barranco, A., Rebolledo-Maldonado, C., Esquiaqui-Rangel, V., Nuñez-Mejia, A., Rambal-Torres, J., Barraza-Ahumada, V., Vargas-Cantillo, S., la Cruz, W. B.-D., Liñán-Martínez, V., Rada-Obeso, V., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311427 · Cited by 8
Gene Editing Therapy in Cardiovascular Disease: 2026 ACC Scientific Statement
Ambardekar, A. V., Bhatt, A., Hoekstra, M., Kelly, M., Musunuru, K., & Natarajan, P. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.02.5092 · Cited by 10
Therapeutic advances in the Lp(a) battle: what do we know and what are the most awaited novelties in the field?
Jean-Gilles, M., & Gencer, B. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000981 · Cited by 8
Lipoprotein apheresis for the treatment of familial hypercholesterolemia
Walji, S., Neuwirth, C. K. Y., & Thompson, G. R. (2013) · Clinical Lipidology · doi:10.2217/clp.13.57 · Cited by 8
Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People – Data from the Berlin Aging Study II
Buchmann, N., Kassner, U., Norman, K., Goldeck, D., Eckardt, R., Pawelec, G., Steinhagen‐Thiessen, E., & Demuth, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139040 · Cited by 8
Lipoprotein(a) and metabolic syndrome—evidence for an inverse association in a pooled cross-sectional analysis of the Berlin Aging Study II (BASE-II) and the Study of Health in Pomerania (SHIP-0)
Buchmann, N., Ittermann, T., Demuth, I., Markus, M. R. P., Völzke, H., Dörr, M., Friedrich, N., Lerch, M. M., Santos, R. D., Schipf, S., et al. (2022) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0153 · Cited by 8
Rhesus monkey ( Macaca mulatta ) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms
Enkhmaa, B., Abbuthalha, A., Anuurad, E., Zhang, W., Tarantal, A. F., & Berglund, L. (2015) · Journal of Medical Primatology · doi:10.1111/jmp.12160 · Cited by 8
How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention
Benes, L. B., Brandt, D. J., Brandt, E. J., & Davidson, M. H. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1079-3 · Cited by 8
Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study
Huang, Z., Yang, Y., Lü, J., Liang, J., He, Y., Yu, Y., Huang, H., Li, Q., Wang, B., Li, S., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.747120 · Cited by 8
The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: Results of a 2021 national survey
Ansari, S., Neely, R. D. G., Payne, J., & Cegla, J. (2023) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632231210682 · Cited by 7
Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients
Rouhani, B., Ghaderian, S. M. H., & Salehi, Z. (2018) · Human Antibodies · doi:10.3233/hab-180353 · Cited by 7
Genetics of Coagulation: What the Cardiologist Needs to Know
Anderson, J. A. M., Lim, W., & Weitz, J. I. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.10.024 · Cited by 7
Capitalizing on Insights from Human Genetics to Identify Novel Therapeutic Targets for Coronary Artery Disease
Young, E. P., & Stitziel, N. O. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-041717-085853 · Cited by 7
The Role of Lipoprotein(a) in the Development of Peripheral and Carotid Atherosclerosis
Tmoyan, N. A., Afanasieva, O. I., & Владиславович, Е. М. (2018) · Kardiologiia · doi:10.18087/cardio.2018.6.10135 · Cited by 7
Association of lipoprotein (a) with coronary artery disease in a South Asian population: A case-control study
Joseph, J., Menon, J. C., Sebastien, P. K., Sudhakar, A., John, D., & Menon, G. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267807 · Cited by 7
Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome
Enkhmaa, B., Anuurad, E., Zhang, W., Abbuthalha, A., Kaur, P., Visla, J., Karakas, S. E., & Berglund, L. (2015) · Clinical Endocrinology · doi:10.1111/cen.12937 · Cited by 7
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Grützmacher, P., Öhm, B., Szymczak, S., Dorbath, C., Brzoska, M., & Kleinert, C. (2017) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-017-0090-3 · Cited by 7
Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3–5 chronic kidney disease undergoing coronary angiography
Lin, L.-H., Liu, H., Tu, Y., Yang, Y. F., Wang, B., Wang, F., Wu, M. J., Pan, M., Tang, R., Ma, K., et al. (2018) · Coronary Artery Disease · doi:10.1097/mca.0000000000000692 · Cited by 7
Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
Afanasieva, O. I., & Pokrovsky, S. N. (2019) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2019-5-101-108 · Cited by 7
Lipoprotein(a): The Renaissance of an Enigmatic Lipoprotein
Dullaart, R. P. F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz111 · Cited by 7
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms
Chemello, K., Blom, D. J., Marais, A. D., Lambert, G. C., & Blanchard, V. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01016-8 · Cited by 7
Association of lipoprotein(a) and LPA gene with calcific aortic valve disease
Yu, X.-Y., Fu, Z.-A., Yu, M., & Shi, Y.-B. (2025) · European Journal of Medical Research · doi:10.1186/s40001-025-03071-8 · Cited by 7
Major cardiovascular events in first-degree relatives of individuals with elevated plasma lipoprotein(a): a registry-based cohort study
Kindborg, G., Hogling, D. E., Häbel, H., Yan, J., Hallerbäck, T., Lindhe, Ö., Hagström, E., Andersson, D. P., Littmann, K., & Brinck, J. W. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf677 · Cited by 7
Lipoprotein(a) Testing and Emerging Therapies
Mayo-Malasky, P., & Frishman, W. H. (2019) · Cardiology in Review · doi:10.1097/crd.0000000000000295 · Cited by 6
Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults
Yuen, T., Mancini, G. B. J., Hegele, R. A., & Pearson, G. J. (2023) · CJC Open · doi:10.1016/j.cjco.2023.11.015 · Cited by 6
Serum levels of Lp(a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities
Tarantino, G., Finelli, C., Gioa, S., Citro, V., Sala, N. L., & Gentile, M. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2016.1207249 · Cited by 6
Acute and Chronic Impact of Biliopancreatic Diversion with Duodenal Switch Surgery on Plasma Lipoprotein(a) Levels in Patients with Severe Obesity
Després, A.-A., Piché, M., Auclair, A., Biertho, L. D., Marceau, S., Hould, F., Biron, S., Lebel, S., Lescelleur, O., Julien, F., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04450-2 · Cited by 7
Fifty years of lipoprotein(a) – the Magical Mystery Tour continues
Angelin, B. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12013 · Cited by 6
Targeted proteomics using stable isotope labeled protein fragments enables precise and robust determination of total apolipoprotein(a) in human plasma
Hober, A., Rekanovic, M., Forsström, B., Hansson, S., Kotol, D., Percy, A. J., Uhlén, M., Oscarsson, J., Edfors, F., & Miliotis, T. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281772 · Cited by 6
Oral agents for lowering lipoprotein(a)
Nicholls, S. J., Nelson, A. J., & Michael, L. F. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000953 · Cited by 5
Lipoprotein(a) in atherosclerotic cardiovascular disease and proprotein convertase subtilisin/kexin-type 9 inhibitors
Lian, P., Zhu, W.-Q., Zhao, W.-X., Huang, P., Ran, J., Tang, Y., Huang, X., & Li, R. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119982 · Cited by 5
Lipoprotein(a): An update on its role in human health and disease
Koutsogianni, A.-D., Liberopoulos, E. N., & Tselepis, A. D. (2021) · Journal of Atherosclerosis Prevention and Treatment · doi:10.53590/japt.02.1028 · Cited by 5
Supporting evidence for lipoprotein(a) measurements in clinical practice
Matveyenko, A., Pavlyha, M., & Reyes‐Soffer, G. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101746 · Cited by 6
Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003–2018
Liu, Z., Fu, Q., Yu, Q., Ma, X., & Yang, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1418835 · Cited by 5
Association Between Genetically Determined Serum Corin and the Risk of Stroke in Chinese Adults: A Mendelian Randomization Study
Liu, Y., Chen, L., Sun, G., Zhang, H., Geng, W., Li, X., Zhang, Q., Jin, Y., Yao, J., Yang, X., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035858 · Cited by 6
Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases
Shah, P. K. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0993-8 · Cited by 5
Causal effect of Lipoprotein-associated phospholipase A2 activity on coronary artery disease and myocardial Infarction: A Two-Sample Mendelian Randomization study
Sun, L., Zhu, Z., Shi, M., Jia, Y., Yang, P., Wang, Y., Liu, F., & Zhang, Y. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.10.039 · Cited by 5
Current concept and residual issues of lipoprotein(a) determination for a cardiovascular risk factor
Yoshida, H., Hirowatari, Y., Ogura, M., & Harada‐Shiba, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13700 · Cited by 5
Clinical Impact and Significance of Serum Lipoprotein (a) Levels on Cardiovascular Risk in Patients With Coronary Artery Disease
Yoshida, H. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0221 · Cited by 5
Elevated lipoprotein(a) and progression of aortic stenosis measured by Doppler echocardiography: A population‐based cohort study
Brinck, J. W., Littmann, K., Hogling, D. E., Widman, L., Caidahl, K., Eriksson, M. J., Johnson, J., Szummer, K. E., & Bäck, M. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20095 · Cited by 4
Current perspectives on Lp(a)-lowering therapies: Who may benefit?
Nicholls, S. J., & Nelson, A. J. (2025) · Kardiologia Polska · doi:10.33963/v.phj.106327 · Cited by 5
Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization
Barbieri, G., Cassioli, G., Kura, A., Orsi, R., Magi, A., Berteotti, M., Scaturro, G. M., Lotti, E., Gori, A. M., Marcucci, R., et al. (2024) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24998 · Cited by 4
Peripheral artery disease risk factors: A focus on lipoprotein(a)
Vestra, M. D., Grolla, E., Autiero, G., & Presotto, F. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.07.061 · Cited by 4
Recurrent Embolic Strokes of Undetermined Source in a Patient with Extreme Lipoprotein(a) Levels
Bulwa, Z. B., Kim, A., Singh, K., Kantorovich, A., & Suhail, F. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00144 · Cited by 4
Genetic and nutritional factors determining circulating levels of lipoprotein(a): results of the “Montignoso Study”
Sereni, A., Sticchi, E., Gori, A. M., Magi, A., Latta, D. D., Volta, A., Murri, A., Jamagidze, G., Chiappino, D., Abbate, R., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02276-5 · Cited by 4
Lipoprotein(a) - the cardiovascular risk factor: significance and therapeutic possibilities
Blaha, V. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.167 · Cited by 4
Lipoprotein(a)—When to Screen and How to Treat
Patel, N., Mittal, N., Choubdar, P. A., & Taub, P. R. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00698-8 · Cited by 4
Role of lipoprotein(a) in plaque progression
Ruscica, M., Rizzuto, A. S., & Corsini, A. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac071 · Cited by 4
Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients
Liu, J., Liu, L., Wang, B., Chen, S., Liu, B., Liang, J., Huang, H., Li, Q., Lun, Z., Ying, M., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.670859 · Cited by 4
A sense of excitement for a specific Lp(a)-lowering therapy
Stroes, E. S. G., & van der Valk, F. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60638-9 · Cited by 4
ESC-Leitlinien 2016 – Dyslipidämien
Sinning, D., & Landmesser, U. (2016) · Herz · doi:10.1007/s00059-016-4505-6 · Cited by 5
Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis
Jamialahmadi, T., Mirhadi, E., Reiner, Ž., Abass, K. S., Almahmeed, W. A., Virani, S. S., & Sahebkar, A. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01346-3 · Cited by 3
Familiäre Hypercholesterinämie – Diagnose und Therapie
Schöb, M., Müller, P., Gerth, Y., Korte, W. C., Rickli, H., Brändle, M., Bärlocher, A., & Bilz, S. (2018) · Praxis · doi:10.1024/1661-8157/a003134 · Cited by 3
The Kidney Is the Heart of the Organs: Its Role in Lp(a) Physiology and Pathophysiology
Dieplinger, H. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-24575-6_12 · Cited by 3
Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration?
Giammanco, A., Noto, D., Nardi, E., Gagliardo, C. M., Scrimali, C., Brucato, F., Spina, R., Barbagallo, C. M., Caldarella, R., Ciaccio, M., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.08.016 · Cited by 3
Similar Myocardial Perfusion and Vascular Stiffness in Children and Adolescents with High Lipoprotein (a) Levels, in Comparison with Healthy Controls
Papadopoulou‐Legbelou, K., Triantafyllou, Α., Vampertzi, O., Koletsos, N., Δούμα, Σ., & Papadopoulou‐Alataki, E. (2021) · Pulse · doi:10.1159/000517871 · Cited by 3
Thrombosis, Inflammation, and Lipoprotein(a): Clinical Implications
Safarova, M. S., & Moriarty, P. M. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-24575-6_11 · Cited by 3
Lipoprotein(a) As a Risk Factor in a Cohort of Hospitalised Cardiovascular Patients: A Retrospective Clinical Routine Data Analysis
Šuran, D., Završnik, T., Kokol, P., Kokol, M., Sinkovič, A., Naji, F. H., Završnik, J., Vošner, H. B., & Kanič, V. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093220 · Cited by 3
Association of Renal Function and Statin Therapy with Lipoprotein(a) in Patients with Type 2 Diabetes
Hiraishi, C., Matsui, S., Kojima, T., Sato, R., Ando, K., Fujimoto, K., & Yoshida, H. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64261 · Cited by 3
Lipoprotein(a) in patients with breast cancer after chemotherapy: exploring potential strategies for cardioprotection
Wang, Z., & Li, J. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01926-9 · Cited by 3
Elevated Plasma Lipoprotein(a) Level and Atherosclerotic Cardiovascular Disease Risks: A Large Clinical Retrospective Study
Wang, K., Wang, W., Niu, J., Liu, X., Han, H., Shen, H., Sun, Y., Gao, W., & Ge, H. (2024) · Angiology · doi:10.1177/00033197241239688 · Cited by 4
Lipoprotein(a) in Children and Adolescents: Risk or Causal Factor for Cardiovascular Disease? A Narrative Review
Capra, M. E., Biasucci, G., Banderali, G., & Pederiva, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168817 · Cited by 4
Lipoprotein(a) Response to Dietary Saturated Fat Reduction: Relationship to Apolipoprotein(a) Size Polymorphism in African Americans
Law, H. G., Myagmarsuren, M., Bang, H., Zhang, W., Lefevre, M., Berglund, L., & Enkhmaa, B. (2025) · Nutrients · doi:10.3390/nu17030426 · Cited by 3
Determination of the biological variation and reference change value of lipoprotein (a)
Antwi, K., DOWNIE, P. F., & Mbagaya, W. (2025) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632251324063 · Cited by 3
Analysis of lipid metabolism and its impact on the risk of ischemic heart disease in patients with definite familial hypercholesterolemia
Korneva, V. A., Kuznetsova, Т. Y., & Julius, U. (2017) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2017.05.008 · Cited by 3
Genetische Erkrankungen des Lipidstoffwechsels
März, W., Beil, F.-U., & Dieplinger, H. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1516-2541 · Cited by 3
Lipoprotein(a)
Koschinsky, M. L., Boffa, M. B., & Marcovina, S. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00010-4 · Cited by 3
Elevated Lp(a) and Abdominal Aortic Aneurysm
Alexandrou, A. T., & Tsimikas, S. (2016) · Angiology · doi:10.1177/0003319716650960 · Cited by 3
Comprehensive Analysis of the Genetic Variation in the LPA Gene from Short-Read Sequencing
Betschart, R. O., Koliopanos, G., Garg, P., Guo, L., Rossi, M., Schönherr, S., Blankenberg, S., Twerenbold, R., Zeller, T., & Ziegler, A. (2024) · BioMed · doi:10.3390/biomed4020013 · Cited by 2
Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory
Velilla, T. A., Fernández‐Prendes, C., Amigó, N., Calmarza, P., Anguila, S. C., Estébanez, B. C., Castro, M. J. C., Ceacero-Marín, D., Martínez, I. G., Palencia, M. M., et al. (2025) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2025-0034 · Cited by 2
Lipoprotein(a): structural basis, bidirectional risk, and therapeutic frontiers
Xu, Z., Fang, Y., Peng, Y., Zhang, C., & Zheng, C. (2025) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.25-94 · Cited by 2
The predictive value of serum lipoprotein(a) level for new-onset aortic valve calcification in patients with coronary artery disease
Ren, Y., & Deng, Y. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05196-4 · Cited by 2
Lp(a) in the Horizon of Diagnostics and Therapy
Formisano, P., Vianello, E., Dozio, E., Tacchini, L., Romani, L. R., Frati, L., Curcio, F., Bellet, M. M., & Corsi-Romanelli, M. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010290 · Cited by 3
Are we underestimating the benefits of lipid-lowering therapies?
Pirillo, A., Casula, M., Olmastroni, E., Scotti, S., Corsini, A., & Catapano, A. L. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100140 · Cited by 2
Lack of Correlation of Carotid Intima-Media Index and Peripheral Artery Disease
Laguna, P., Robles, N. R., Gómez, J. L., Barroso, S., & Collado, G. (2018) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0282-z · Cited by 2
Lipoprotein(а) Level, Apolipoprotein(а) Polymorphism аnd Autoаntibodies Against Lipoprotein(а) in Patients with Stenotic Cаrotid Atherosclerosis
Tmoyan, N. A., Afanasieva, O. I., Владиславович, Е. М., Александровна, К. Е., Afanasieva, M. I., Андреевна, Р. О., Balakhonova, T. V., & Pokrovsky, S. N. (2019) · Kardiologiia · doi:10.18087/cardio.2019.12.n727 · Cited by 2
Lipoprotein(a) and kidney diseases
Pyatchenkov, M. O., Rumyantsev, A. S., Владимирович, З. М., Sherbakov, E. V., & Belskykh, A. N. (2021) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2021-25-1-31-46 · Cited by 3
Lipoprotein(a) Concentrations Correlate With LDL-C in Children With Type 1 and 2 Diabetes
Foster, C., Rahman, A. K. M. F., & Ashraf, A. P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab138 · Cited by 2
Association between lipoprotein(a) plasma levels and diabetic nephropathy in Han Chinese patients with type 2 diabetes mellitus
Wang, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299240 · Cited by 2
Association between lipoprotein levels and outcomes after coronary artery bypass grafting surgery: a systematic review and meta-analysis
Cancelli, G., Harik, L., Ibrahim, M., Hameed, I., Rossi, C. S., Caldonazo, T. M. M., Dell'Aquila, M., Soletti, G. J., An, K. R., LEITH, J., et al. (2024) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.24.06534-7 · Cited by 2
Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist
Belanger, M. J., Kelly, E. M., Tahir, U. A., & Benson, M. D. (2021) · Cardiology in Review · doi:10.1097/crd.0000000000000384 · Cited by 2

Authors: Kronenberg, F., & Utermann, G.
Affiliations: Innsbruck Medical University (AT)
Corresponding author: Utermann, G.
ORCID: Kronenberg, F.
Venue: Journal of Internal Medicine
Publisher: Wiley
Published: 2012-11-12
Volume: 273
Issue: 1
Pages: 6-30
ISSN: 0954-6820 (ISSN-L)
1365-2796
DOI: 10.1111/j.1365-2796.2012.02592.x
OpenAlex: W1988877980
Cited by: 521
References: 203
Citations by year: 2026: 40 · 2025: 38 · 2024: 39 · 2023: 41 · 2022: 45 · 2021: 42 · 2020: 36 · 2019: 48 · 2018: 35 · 2017: 36 · 2016: 42 · 2015: 38 · 2014: 20 · 2013: 17 · 2012: 2
FWCI: 4.75
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Austrian Science Fund
Oesterreichische Nationalbank
Standortagentur Tirol
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords: lipoprotein(a), LPA gene, coronary heart disease risk, genetic risk factors, Mendelian randomization, apheresis, cardiovascular risk reduction
MeSH terms: Alleles, Coronary Artery Disease, DNA, Gene Frequency, Humans, Polymorphism, Genetic, Lipoprotein(a), Genetic Predisposition to Disease, Mendelian Randomization Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lipoprotein(a): resurrected by genetics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks